Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2014 · 10-Q
Revenue$139.00$139.00−44.8% vs Q3 2013 Net Income-$6.12K-$6.12KN/M vs Q3 2013 EPS Diluted$0.00$0.00— vs Q3 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Margins · derivedGross margin100.0%±0.0 pt vs Q3 2013
Operating margin-4402.9%−2525.9 pt vs Q3 2013
Net margin-4402.9%−2366.8 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 19, 2014 · 50 d after period end